References
-
1) Exosomes derived from mesenchymal stem cells curbs the progression of clear cell renal cell carcinoma through T-cell immune response.
Product: VEGFA Antibody (#AF5131)Year: 2021Journal: CYTOTECHNOLOGYImpactFactor: 2DOI: 10.1007/s10616-021-00480-5PMID: 34349349 -
2) Phosphatidylcholine‐Engineered Exosomes for Enhanced Tumor Cell Uptake and Intracellular Antitumor Drug Delivery.
Product: VEGFA Antibody (#AF5131)Year: 2021Journal: MACROMOL BIOSCIImpactFactor: 4.4DOI: 10.1002/mabi.202100042PMID: 33949800 -
3) N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation.
Product: VEGFA Antibody (#AF5131)Year: 2021Journal: EUR J MED CHEMImpactFactor: 6DOI: 10.1016/j.ejmech.2021.113817PMID: 34537445 -
4) Design, synthesis and biological evaluation of N-anthraniloyl tryptamine derivatives as pleiotropic molecules for the therapy of malignant glioma.
Product: VEGFA Antibody (#AF5131)Year: 2021Journal: EUR J MED CHEMImpactFactor: 6DOI: 10.1016/j.ejmech.2021.113564PMID: 34091208 -
5) Production of an Animal Model of Semi-Yin and Semi-Yang Syndrome with Diabetic Ulcers and Study of Its Pathological and Metabolic Features.
Product: VEGFA Antibody (#AF5131)Year: 2021Journal: EVID-BASED COMPL ALTDOI: 10.1155/2021/6345147PMID: 34257687 -
6) CircDIP2C ameliorates oxidized low-density lipoprotein-induced cell dysfunction by binding to miR-556-5p to induce TET2 in human umbilical vein endothelial cells.
Product: VEGFA Antibody (#AF5131)Year: 2021Journal: VASC PHARMACOLImpactFactor: 3.5DOI: 10.1016/j.vph.2021.106887PMID: 34147657 -
7) The effect of MMP-2 inhibitor 1 on osteogenesis and angiogenesis during bone regeneration.
Product: VEGFA Antibody (#AF5131)Year: 2021Journal: FRONT CELL DEV BIOLImpactFactor: 4.6DOI: 10.3389/fcell.2020.596783PMID: 33553142 -
8) Formulated citrus peel extract gold lotion improves cognitive and functional recovery from traumatic brain injury (TBI) in rats.
Product: VEGFA Antibody (#AF5131)Year: 2020Journal: FOOD SCI HUM WELLImpactFactor: 7DOI: 10.1016/j.fshw.2020.04.012 -
9) Gene-activated engineered exosome directs osteoblastic differentiation of progenitor cells and induces vascularized osteogenesis in situ.
Product: VEGFA Antibody (#AF5131)Year: 2020Journal: CHEM ENG JImpactFactor: 13.3DOI: 10.1016/j.cej.2020.125939 -
10) Angiogenic and anti-inflammatory properties of azadirachtin A improve random skin flap survival in rats.
Product: VEGFA Antibody (#AF5131)Year: 2020Journal: Exp Biol Med (Maywood)ImpactFactor: 2.8DOI: 10.1177/1535370220951896PMID: 32867550 -
11) Mechanical stress promotes angiogenesis through fibroblast exosomes.
Product: VEGFA Antibody (#AF5131)Year: 2020Journal: BIOCHEM BIOPH RES COImpactFactor: 2.5DOI: 10.1016/j.bbrc.2020.04.159PMID: 32962863 -
12) Changes in neurological and pathological outcomes in a modified rat spinal cord injury model with closed canal.
Product: VEGFA Antibody (#AF5131)Year: 2020Journal: NEURAL REGEN RESImpactFactor: 5.9DOI: 10.4103/1673-5374.266919PMID: 31638094 -
13) Co‐overexpression of VEGF and GDNF in adipose‐derived stem cells optimizes therapeutic effect in neurogenic erectile dysfunction model.
Product: VEGFA Antibody (#AF5131)Year: 2020Journal: CELL PROLIFERATImpactFactor: 5.9DOI: 10.1111/cpr.12756PMID: 31943490 -
14) β1 adrenoceptor antibodies induce myocardial apoptosis via inhibiting PGC-1α- related pathway.
Product: VEGFA Antibody (#AF5131)Year: 2020Journal: BMC CARDIOVASC DISORImpactFactor: 2DOI: 10.1186/s12872-020-01492-3PMID: 32503464 -
15) The effect of Shu Xue Tong treatment on random skin flap survival via the VEGF-Notch/Dll4 signaling pathway.
Product: VEGFA Antibody (#AF5131)Year: 2020Journal: J INVEST SURGImpactFactor: 2.1DOI: 10.1080/08941939.2018.1551948PMID: 30644800